CLINICAL_TRIALS
trial_result
· 2012-06-04
Clinical Trial Update: Safety Assessment of a Multipeptide-gene Vaccine in CML [Phase 1]
Summary
This Phase 1 clinical trial update reports safety assessment data for a multipeptide-gene vaccine in chronic myeloid leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tehran University of Medical Sciences | Conditions: Leukemia, Myeloid, Chronic | Phase 1 | Status: COMPLETED